InvestorsHub Logo
Followers 58
Posts 10324
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Sunday, 06/06/2021 6:21:02 PM

Sunday, June 06, 2021 6:21:02 PM

Post# of 470160
Just in case you have not seen the latest NYT pub-today.

https://www.yahoo.com/news/alzheimers-drug-poses-dilemma-fda-151036062.html

Alzheimer's Drug Poses a Dilemma for the FDA

“I simply don’t see a path for approval because of the absence of evidence that’s been shared to date that this product works, and I think it would set a remarkably dangerous precedent — not only for the field of Alzheimer’s research but also for the broader regulation of prescription drugs in our country,” said Dr. G. Caleb Alexander, an FDA advisory committee member and an internist, public health researcher and drug safety and effectiveness expert at the Johns Hopkins Bloomberg School of Public Health.




Kinda reminds me of the old ,"Saturday Night Live bit", where Rozzana Dana says..."Never Mind".

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News